Structural prerequisites for endotoxic activity in the Limulus test as compared to cytokine production in mononuclear cells

The structural prerequisites for lipopolysaccharide (LPS) and its partial structures for the activation of the Limulus clotting cascade (Limulus amebocyte lysate [LAL] test) are described and compared with the corresponding requirements for the activation of human immune cells such as mononuclear cells. A necessary, but not sufficient, structural motif for this is the presence of the 4′-phosphate-diglucosamine backbone recognition structure (‘epitope’) in lipid A. High activity is only expressed by assemblies of endotoxins, but this is largely independent of the type of supramolecular aggregate structure. A particular conformation of the epitope within the lipid A assembly must be present, which is influenced by addition of further saccharide units to the lipid A moiety, but also reacts slightly to the acylation pattern. In contrast, the cytokine production of human immune cells induced by LPS sensitively depends on the type of its aggregate structure. In the case of a hexa-acylated bisphosphorylated lipid A structure, high activity is only observed with cubic inverted aggregates. Furthermore, addition of antimicrobial agents (such as polymyxin B) leads to a nearly complete inhibition of cytokine production, whereas the reduction in the Limulus assay is much lower. These data are important since a reliable determination of endotoxin concentrations, in particular with respect to its ability to elicit severe infections, is of high interest.

[1]  R. Roth,et al.  Purification of Limulus polyphemus proclotting enzyme. , 1992, Journal of Biological Chemistry.

[2]  Samuel I. Miller,et al.  Variation in lipid A structure in the pathogenic yersiniae , 2004, Molecular microbiology.

[3]  B. Lindner,et al.  Aggregates Are the Biologically Active Units of Endotoxin* , 2004, Journal of Biological Chemistry.

[4]  K. Brandenburg,et al.  Divalent cations affect chain mobility and aggregate structure of lipopolysaccharide from Salmonella minnesota reflected in a decrease of its biological activity. , 2005, Biochimica et biophysica acta.

[5]  S. Kusumoto,et al.  Conformational studies of synthetic lipid A analogues and partial structures by infrared spectroscopy. , 1997, Biochimica et biophysica acta.

[6]  R R Schumann,et al.  Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. , 1996, Current topics in microbiology and immunology.

[7]  S. Iwanaga,et al.  Interaction between lipopolysaccharide and intracellular serine protease zymogen, factor C, from horseshoe crab (Tachypleus tridentatus) hemocytes. , 1988, Journal of biochemistry.

[8]  N. Kusunose,et al.  Structural requirements of lipid A species in activation of clotting enzymes from the horseshoe crab, and the human complement cascade. , 1988, European journal of biochemistry.

[9]  H. Heine,et al.  Biophysical characterization of triacyl monosaccharide lipid a partial structures in relation to bioactivity. , 2002, Biophysical journal.

[10]  J. Levin The Limulus amebocyte lysate test: perspectives and problems. , 1987, Progress in clinical and biological research.

[11]  E. Rietschel,et al.  Chemical structure of lipid A , 1985 .

[12]  H. Takada,et al.  Structural requirements of lipid A for endotoxicity and other biological activities. , 1989, Critical reviews in microbiology.

[13]  S. Gronow,et al.  Physicochemical characterization of carboxymethyl lipid A derivatives in relation to biological activity , 2005, The FEBS journal.

[14]  T. Kirikae,et al.  Bacterial endotoxin: molecular relationships of structure to activity and function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  D. Su,et al.  Limulus antilipopolysaccharide factor prevents mortality late in the course of endotoxemia. , 1998, The Journal of infectious diseases.

[16]  R. Roth,et al.  Optimization of detection of bacterial endotoxin in plasma with the Limulus test. , 1990, The Journal of laboratory and clinical medicine.

[17]  D. Bates,et al.  Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Bauer,et al.  Physicochemical characteristics of triacyl lipid A partial structure OM-174 in relation to biological activity. , 2000, European journal of biochemistry.

[19]  T. Hartung,et al.  Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay , 2006 .

[20]  K. Kuma,et al.  Lipopolysaccharide-sensitive serine-protease zymogen (factor C) of horseshoe crab hemocytes. Identification and alignment of proteolytic fragments produced during the activation show that it is a novel type of serine protease. , 1987, European journal of biochemistry.

[21]  K. Brandenburg,et al.  Invited review: Mechanisms of endotoxin neutralization by synthetic cationic compounds , 2006, Journal of endotoxin research.

[22]  J. Peter-Katalinic,et al.  Isolation and characterization of the tetrasaccharide (bis)phosphate from the glycosyl backbone of Salmonella minnesota and Escherichia coli re-mutant lipopolysaccharides , 1993 .

[23]  K. Fukase,et al.  A Divergent Synthesis of Lipid A and Its Chemically Stable Unnatural Analogues. , 1999 .

[24]  T. Kobayashi,et al.  Intracellular serine-protease zymogen, factor C, from horseshoe crab hemocytes. Its activation by synthetic lipid A analogues and acidic phospholipids. , 1988, European journal of biochemistry.

[25]  M. Koch,et al.  Cyclic antimicrobial peptides based on Limulus anti-lipopolysaccharide factor for neutralization of lipopolysaccharide. , 2004, Biochemical pharmacology.

[26]  K. Fukase,et al.  First Total Synthesis of the Re-Type Lipopolysaccharide. , 2001, Angewandte Chemie.

[27]  A. Wiese,et al.  Endotoxins: relationships between structure, function, and activity. , 2004, Current topics in medicinal chemistry.

[28]  K. Brandenburg,et al.  Biophysical investigations into the interaction of lipopolysaccharide with polymyxins , 2002 .

[29]  K. Fukase,et al.  Synthesis of Lipopolysaccharide, Peptidoglycan, and Lipoteichoic Acid Fragments , 2007 .

[30]  K. Fukase,et al.  Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs , 2003, Journal of endotoxin research.

[31]  M. Koch,et al.  Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. , 2000, European journal of biochemistry.

[32]  S. Iwanaga,et al.  Limulus test for detecting bacterial endotoxins. , 1993, Methods in enzymology.

[33]  Buko Lindner,et al.  Biophysical characterization of the interaction of high-density lipoprotein (HDL) with endotoxins. , 2002, European journal of biochemistry.

[34]  K. Brandenburg,et al.  Mechanisms of endotoxin neutralization by synthetic cationic compounds. , 2006 .

[35]  K. Brandenburg,et al.  Physicochemical properties of bacterial glycopolymers in relation to bioactivity. , 2003, Carbohydrate research.

[36]  M. Koch,et al.  Temperature dependence of the binding of endotoxins to the polycationic peptides polymyxin B and its nonapeptide. , 2005, Biophysical journal.

[37]  S. Kusumoto,et al.  Chemical Synthesis of a Biosynthetic Precursor of Lipid A with a Phosphorylated Tetraacyl Disaccharide Structure , 1987 .

[38]  C. Galanos,et al.  A new method for the extraction of R lipopolysaccharides. , 1969, European journal of biochemistry.